1
/
of
1
Elabscience
SKU:E-CL-H0486
Human CNR1(Cannabinoid Receptor 1, Brain) CLIA Kit
Human CNR1(Cannabinoid Receptor 1, Brain) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
The Human CNR1 (Cannabinoid Receptor 1, Brain) CLIA Kit is a highly advanced and reliable diagnostic tool designed for the accurate detection and quantification of CNR1, also known as the Cannabinoid Receptor 1, in human brain samples. This cutting-edge kit utilizes the Chemiluminescent Immunoassay (CLIA) technique, which ensures exceptional sensitivity and specificity in detecting CNR1.
The Cannabinoid Receptor 1 plays a crucial role in the endocannabinoid system, which is involved in various physiological processes such as pain modulation, appetite regulation, and mood control. Dysregulation of CNR1 has been implicated in several neurological disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. Therefore, accurate measurement of CNR1 levels in the brain is of utmost importance for understanding the pathophysiology of these conditions and developing targeted therapeutic interventions.
The Human CNR1 CLIA Kit offers numerous advantages, including its user-friendly protocol, rapid assay time, and wide dynamic range. With its high sensitivity and specificity, this kit enables precise and reproducible quantification of CNR1 levels in human brain samples. It is suitable for use in research laboratories, clinical settings, and pharmaceutical industries, facilitating comprehensive investigations into the role of CNR1 in neurological disorders and the development of novel therapeutic strategies.
The Cannabinoid Receptor 1 plays a crucial role in the endocannabinoid system, which is involved in various physiological processes such as pain modulation, appetite regulation, and mood control. Dysregulation of CNR1 has been implicated in several neurological disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. Therefore, accurate measurement of CNR1 levels in the brain is of utmost importance for understanding the pathophysiology of these conditions and developing targeted therapeutic interventions.
The Human CNR1 CLIA Kit offers numerous advantages, including its user-friendly protocol, rapid assay time, and wide dynamic range. With its high sensitivity and specificity, this kit enables precise and reproducible quantification of CNR1 levels in human brain samples. It is suitable for use in research laboratories, clinical settings, and pharmaceutical industries, facilitating comprehensive investigations into the role of CNR1 in neurological disorders and the development of novel therapeutic strategies.
Share
